Results of a survey show that Black/Indigenous/People of Color or Hispanic patients with Crohn's disease or ulcerative ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...

Gold carding eliminates prior authorization for top-performing labs and eases plan workflows while controlling spending and ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

The FDA has approved Lilly’s Ebglyss (lebrikizumab-lbkz) for the treatment of moderate to severe atopic dermatitis in adults ...

Express Scripts alleges in its suit that the FTC followed “prejudice and politics, not evidence or sound economics,” and that ...

The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

Ocrevus Zunovo can be administrated by providers twice a year with a 10-minute subcutaneous injection. Ocrevus Zunovo will be ...

It seems like a day doesn’t go by without another positive finding for the glucagon-like peptide 1 (GLP-1) receptoragonist ...

An Ohio State University survey found that many adults are hesitant about getting flu, COVID-19, pneumococcal and respiratory ...